Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21398892 | 0.93 | ALDH1A1 (0.32) | MAPK1MCL1 | |
| SCHEMBL21398903 | 0.91 | MAOA (0.33) | KDM4EMAPK1MCL1MAOAMAOB | |
| SCHEMBL21936415 | 0.91 | KDM4E (0.32) | KDM4EMAOAMAOB | |
| SCHEMBL19656457 | 0.89 | MAOA (0.32) | MCL1MAOAMAOB | |
| SCHEMBL21281819 | 0.86 | GPR3 (0.35) | KDM4EMCL1MAOAMAOB | |
| SCHEMBL21398642 | 0.86 | MAPT (0.32) | KDM4EMAPK1MCL1 | |
| SCHEMBL21398782 | 0.86 | MCL1 (0.38) | KDM4EMAPK1MCL1MAOAMAOB | |
| SCHEMBL15852566 | 0.86 | KDM4E (0.33) | KDM4EMAOAMAOB | |
| SCHEMBL21398627 | 0.86 | MAOA (0.32) | MCL1MAOAMAOB | |
| SCHEMBL19656532 | 0.85 | MAOA (0.31) | KDM4EMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190296244-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296244-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | OR51E2, WEE2, WEE1 | KDM4E 1329/4885MAPK1 2567/4885MCL1 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.